adenomyosis造句1. Conclusion Mifepristone could suppress the growth of adenomyosis cells in vitro in a dose dependent manner.
2. Results: 81 cases of patients with adenomyosis or adenomyoma were diagnosed by color doppler ultrasound.
3. The preoperative diagnosis rate of adenomyosis was 72.31% , and the patients with adenomyosis usually suffered from dysmenorrhea (73.08%), dyspareunia (33.08%) and seldom secondary anemia (15.38%) .
4. The exact pathological activity of adenomyosis isn't known completely by us, but held generally that adenomyosis is caused by the direct invasion of endometrium into myometrium.
5. HIFU can ablate human adenomyosis in vitro effectively and do not hurt the tissues around of the ablation.
6. Objective : To explore the possibility of transvaginal ultrasound using on evaluating therapeutic effect adenomyosis.
7. Conclusions:The expression of MMP-2, MMP-7 and TIMP-1 was irrespective of the phase of the menstrual cycle in the ectopic and eutopic endometrium of adenomyosis group .
8. Objectives To investigate the expression of substance P(SP)and calcitonin gene-related peptide(CGRP)in adenomyosis tissues and in eutopic endometrium.
9. Objective To investigate the value that lipiodol ultra fluid selective embolization of uterine artery for adenomyosis.
10. Methods serum CA125 and CA19-9 were measured in 103 endometriosis, 27 had adenomyosis, 41 leiomyoma of uterus and 25 ovarian serous cystadenoma respectively.
11. Method:With MTT assay, the growth state of primary cell culture from adenomyotic implants of 11 women with adenomyosis was studied.
12. AIM : To study the curative effect and feasibility of percutaneous microwave coagulation therapy ( PMCT ) for adenomyosis.
13. Objective: To sum up experience in clinical diagnosis of adenomyosis interna to decrease its misdiagnosis rate.
14. Objective To evaluate the effects of laparoscopic uterine nerve ablation(LUNA)on dysmenorrhea, chronic pelvic pain and dyspareunia of adenomyosis.
15. Objective To assess the clinical efficacy of uterine artery embolization for the treatment of adenomyosis.
16. It has been shown to demonstrate higher sensitivity than transvaginal US ( TVUS ) in diagnosing adenomyosis.
17. The thickened and spongy appearing myometrial wall of this sectioned uterus is typical of adenomyosis.
18. Objective:To explore the clinical value of transvaginal two dimensional and color Doppler ultrasonography in diagnosing uterine leiomyoma , adenomyosis and adenomyoma.
19. This article reviews its applications in the treatment of menorrhagia, endometriosis and adenomyosis as well as the endometria protection during hormone replacement therapy(HRT).
20. Objective To study the expression and clinical significance of MMP 9 in ovarian endometriosis and adenomyosis.
21. To evaluate the value of uterine arterial blocking in the treatment of adenomyosis.
22. Objective To evaluate the influence on ovarian function of patients with adenomyosis after uterine artery embolization with Pingyangmycin lipiodol emulsion (PLE).
23. Objective : To observe the effect of BuShenQuYuXiaoZhengTang ( BSQYXZT ) in treating adenomyosis and to explore its mechanism.
24. Objective To discuss the clinical effect of uterine artery embolization in treating adenomyosis.
25. Purpose : To evaluate transvaginal color Doppler sonography ( TVCDS ) in the diagnosis of adenomyosis.